Quest Diagnostics (DGX) recently announced the completion of its acquisition of LifeLabs from OMERS. The transaction was valued at approximately $1 billion, including net debt. The latest acquisition is aimed at enhancing access to diagnostic innovation for patients in North America. Significance of LifeLabs Acquisition for DGX's Business The combination of LifeLabs' strong business and deep community presence with Quest Diagnostics' specialized lab services and expertise creates an opportunity to generate ...